Bisphosphonate-associated osteonecrosis of the jaw: Does it occur in children?

Abstract

Background: Bisphosphonate use in adult patients has been linked to osteonecrosis of the jaw (ONJ). This complication has not been systematically assessed in a paediatric population receiving bisphosphonates. Objective: To assess our cohort of paediatric patients treated with intravenous bisphosphonate for occurrence of ONJ. Design: Observational study at a tertiary children's hospital. Patients: A total of 42 paediatric patients with osteoporosis who received bisphosphonate infusions for a mean of 6.5 years (SD 2.7 years) were assessed clinically and radiographically for possible ONJ. Among 42, 37 patients had received disodium pamidronate 1 mg/kg/dose at a mean cumulative dose of 19.8 mg/k..